The Gofen & Glossberg LLC IL decides to keep it stake in Anthem Inc. (ANTM) to the level of $374,000

The Gofen & Glossberg LLC IL decides to keep it stake in Anthem Inc. (ANTM) to the level of $374,000

Gofen & Glossberg LLC IL lowered its stake in Anthem Inc. (NYSE:ANTM) by 0.4% during the third quarter, according to its most recent disclosure with the SEC. The firm owned 2,983 shares of the company’s stock after selling 11 shares during the period. Gofen & Glossberg LLC IL’s holdings in Anthem were worth $374,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Breton Hill Capital Ltd. increased its stake in shares of Anthem by 12.7% in the second quarter. Breton Hill Capital Ltd. now owns 7,435 shares of the company’s stock worth $977,000 after buying an additional 837 shares during the period. Atria Investments LLC acquired a new stake in shares of Anthem during the second quarter worth about $570,000. Chevy Chase Trust Holdings Inc. increased its stake in shares of Anthem by 1.8% in the second quarter. Chevy Chase Trust Holdings Inc. now owns 225,985 shares of the company’s stock worth $29,681,000 after buying an additional 4,040 shares during the period. Exxonmobil Investment Management Inc. TX increased its stake in shares of Anthem by 7.0% in the second quarter. Exxonmobil Investment Management Inc. TX now owns 68,065 shares of the company’s stock worth $8,940,000 after buying an additional 4,432 shares during the period. Finally, DNB Asset Management AS increased its stake in shares of Anthem by 10.3% in the second quarter. DNB Asset Management AS now owns 72,750 shares of the company’s stock worth $9,555,000 after buying an additional 6,800 shares during the period. 89.13% of the stock is owned by hedge funds and other institutional investors.

Shares of Anthem Inc. (NYSE:ANTM) traded up 0.78% during midday trading on Friday, reaching $144.74. The company’s stock had a trading volume of 1,231,477 shares. The stock has a market capitalization of $38.13 billion, a PE ratio of 16.99 and a beta of 0.57. The stock’s 50 day moving average is $127.61 and its 200 day moving average is $129.41. Anthem Inc. has a 12 month low of $114.85 and a 12 month high of $148.00.

Anthem (NYSE:ANTM) last released its quarterly earnings results on Wednesday, November 2nd. The company reported $2.45 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.47 by $0.02. The business had revenue of $21.13 billion for the quarter, compared to the consensus estimate of $20.77 billion. Anthem had a net margin of 2.74% and a return on equity of 11.64%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the firm posted $2.73 EPS. On average, analysts forecast that Anthem Inc. will post $10.81 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 21st. Stockholders of record on Monday, December 5th will be issued a dividend of $0.65 per share. The ex-dividend date of this dividend is Thursday, December 1st. This represents a $2.60 dividend on an annualized basis and a dividend yield of 1.80%. Anthem’s dividend payout ratio (DPR) is presently 30.52%.

Several research firms have recently weighed in on ANTM. Cantor Fitzgerald set a $125.00 target price on Anthem and gave the company a “hold” rating in a report on Wednesday, November 2nd. Leerink Swann boosted their target price on Anthem from $155.00 to $160.00 and gave the company an “outperform” rating in a report on Thursday, November 3rd. FBR & Co reissued a “market perform” rating and issued a $155.00 target price on shares of Anthem in a report on Monday, August 15th. Zacks Investment Research raised Anthem from a “sell” rating to a “hold” rating in a report on Monday, November 7th. Finally, Wolfe Research raised Anthem from a “market perform” rating to an “outperform” rating in a research note on Tuesday. Eight analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $158.05.

In related news, SVP Ronald W. Penczek sold 820 shares of the business’s stock in a transaction that occurred on Tuesday, November 22nd. The stock was sold at an average price of $138.29, for a total transaction of $113,397.80. Following the sale, the senior vice president now owns 1,320 shares of the company’s stock, valued at $182,542.80. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Joseph Swedish sold 24,513 shares of the business’s stock in a transaction that occurred on Friday, November 11th. The stock was sold at an average price of $131.48, for a total value of $3,222,969.24. Following the sale, the insider now directly owns 87,381 shares in the company, valued at approximately $11,488,853.88. The disclosure for this sale can be found here. Insiders own 0.37% of the company’s stock.

About Anthem

Anthem, Inc is a health benefit company. The Company offers a range of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. The Company has three segments: Commercial and Specialty Business, Government Business and Other. The Company’s Commercial and Specialty Business, and Government Business segments offer managed care products, including preferred provider organizations (PPOs), health maintenance organizations (HMOs), traditional indemnity benefits and point-of-service (POS) plans, as well as various hybrid benefit plans, including consumer-driven health plans (CDHPs), hospital only and limited benefit products.

Related posts

Leave a Comment